Researchers mapped SARS-CoV-2 RNA-protein interactions and reduced replication in cultured cells. A treatment remains unproven.
Lifelong Learning is the path to Insights
Researchers mapped SARS-CoV-2 RNA-protein interactions and reduced replication in cultured cells. A treatment remains unproven.
Regeneron’s results distinguish its own revenue from global Dupixent sales recorded by Sanofi. Here is why that distinction matters.
MIT researchers tested implanted magnetic sensors in three people with amputations. The study measured cursor control, not walking with a prosthesis.
AbbVie’s immunology revenue grew as Skyrizi and Rinvoq rose and Humira declined. Here is what the shifting portfolio means for investors.
A UC Davis experiment found local benefits for young clams when crushed shells were added to sediment. Here is what the study does and does not show.
Colgate-Palmolive reported higher sales and margins. Here is how reported and organic growth differ, and what investors should examine.
MIT researchers adjusted antigen density on bacteriophage particles in mouse cancer vaccine experiments. Human treatments remain unproven.
Cornell researchers found two superconducting states can coexist in uranium ditelluride. A topological state remains unproven.
The employment cost index rose, while inflation-adjusted private wages fell. Here is what the data mean for workers, companies and investors.
The Nasdaq fell 2.9% on October 30 as technology shares slid. Here’s what the selloff means for indexes, ETFs and long-term investors.